SCHEMBL7690188

SCHEMBL7690188

CCCCC(NC(=O)c1cccc(NS(=O)(=O)c2ccccc2)c1)C(=O)CNS(=O)(=O)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.48
FGFR1 P11362 3/20 0.48
KDR P35968 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
PFKFB3 Q16875 1/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46
HDAC10 Q969S8 1/20 0.46
HDAC11 Q96DB2 1/20 0.46
HDAC9 Q9UKV0 1/20 0.46
HDAC5 Q9UQL6 1/20 0.46
WDR5 P61964 1/20 0.44
PLAU P00749 1/20 0.44
HPN P05981 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7686060 0.94 EGFR (0.46) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7680584 0.93 AKR1C3 (0.48) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7689333 0.91 OPRM1 (0.47) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7661487 0.91 EGFR (0.47) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7665441 0.90 EGFR (0.46) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7564537 0.89 CA2 (0.54) CA2
SCHEMBL7682371 0.87 FABP1 (0.46) MEN1KMT2AMAPT
SCHEMBL7694503 0.87 KDR (0.43) EGFRFGFR1KDRMEN1KMT2A
SCHEMBL7427436 0.85 AKR1C3 (0.45) MEN1KMT2AHDAC8HDAC6HDAC2
SCHEMBL7682470 0.83 ALDH1A1 (0.51) MEN1KMT2AHDAC8HDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6436925-B1 BETTER ABLE TO CROSS MEMBRANES; INHIBITORS OF CYSTEINE PROTEASES LIKE CALPAIN I AND II AND CATHEPSIN B AND L, CAN THUS BE USED TO CONTROL DISEASES ASSOCIATED WITH AN ELEVATED ACTIVITY OF CALPAIN ENZYMES OR CATHEPSIN ENZYMES ABBOTT LABORATORIES 2002-08-20 US disclosed